Diabetes [dsyn]    
CIRRHOSIS [dsyn]    
Risk Factors [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
successful treatment [clna]    
Chronic hepatitis C [dsyn]    
successful treatment [clna]    
Hepatitis C virus infection [dsyn]    
HEPATOCELLULAR CARCINOMA [neop]    
CURRENT [tmco]    
Guidelines [inpr]    
recommend [idcn]    
Continued Surveillance [hlca]    
HEPATOCELLULAR CARCINOMA [neop]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Study [mnob]    
investigate [ftcn]    
Risk Factors [qnco]    
Incidence Rate [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
HEPATITIS C VIRUS [virs]    
Patients [podg]    
Pretreatment [sbst]    
Advanced [qlco]    
LIVER DISEASE [dsyn]    
Stage [tmco]    
Methods [inpr]    
Patients [podg]    
advanced disease [fndg]    
LIVER [bpoc]    
Treated [ftcn]    
HEPATITIS C VIRUS [virs]    
Median [spco]    
7-8 [fndg]    
YEARS [tmco]    
national [popg]    
Registries [inpr]    
Loss [qnco]    
Incidence Rate [qnco]    
Hazard Ratio [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Calculated [ftcn]    
Regression Analysis [inpr]    
Seventeen [qnco]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
Person [popg]    
YEARS [tmco]    
HEPATOCELLULAR CARCINOMA [neop]    
Incidence Rate [qnco]    
Person [popg]    
YEARS [tmco]    
Patients [podg]    
Pretreatment [sbst]    
Patients [podg]    
Pretreatment [sbst]    
CIRRHOSIS [dsyn]    
Diabetes [dsyn]    
HEPATOCELLULAR CARCINOMA [neop]    
Incidence Rate [qnco]    
7 - 9 [fndg]    
Person [popg]    
YEARS [tmco]    
YEARS [tmco]    
HEPATOCELLULAR CARCINOMA [neop]    
Decreased [qnco]    
YEARS [tmco]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Conclusions [idcn]    
DIABETES MELLITUS [dsyn]    
CIRRHOSIS [dsyn]    
Strong [qlco]    
Risk Factors [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
HEPATOCELLULAR CARCINOMA [neop]    
diminish [qnco]    
YEARS [tmco]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Patients [podg]    
CIRRHOSIS [dsyn]    
Low Risk [fndg]    
HEPATOCELLULAR CARCINOMA [neop]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Benefit [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
surveillance [ftcn]    
Group [idcn]    
Questionable [qlco]    
